Viewing Study NCT00769067


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-06-08 @ 3:56 PM
Study NCT ID: NCT00769067
Status: COMPLETED
Last Update Posted: 2015-10-07
First Post: 2008-10-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lung cancer View
None advanced View
None second or third line View